HUP0001515A2 - Pharmaceutical compositions containing cyclosporin - Google Patents
Pharmaceutical compositions containing cyclosporinInfo
- Publication number
- HUP0001515A2 HUP0001515A2 HU0001515A HUP0001515A HUP0001515A2 HU P0001515 A2 HUP0001515 A2 HU P0001515A2 HU 0001515 A HU0001515 A HU 0001515A HU P0001515 A HUP0001515 A HU P0001515A HU P0001515 A2 HUP0001515 A2 HU P0001515A2
- Authority
- HU
- Hungary
- Prior art keywords
- cyclamen
- fatty acid
- pharmaceutical compositions
- compositions containing
- powder
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
- 229930105110 Cyclosporin A Natural products 0.000 title 1
- 108010036949 Cyclosporine Proteins 0.000 title 1
- 229960001265 ciclosporin Drugs 0.000 title 1
- 229930182912 cyclosporin Natural products 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 3
- 241000612153 Cyclamen Species 0.000 abstract 2
- 229930186364 cyclamen Natural products 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 2
- 239000011707 mineral Substances 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 239000004575 stone Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002015 acyclic group Chemical group 0.000 abstract 1
- 229930013930 alkaloid Natural products 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- -1 carbon chain fatty acid triglycerides Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000005456 glyceride group Chemical group 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 239000003350 kerosene Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány tárgya egy ciklőspőrintartalmú kőmpőzíciót tartalmazókészítmény. A készítményt azzal jellemezi, hőgy őlyan kőmpőzícióttartalmaz, amelyben 1) hatóanyagként ciklőspőrin; 2) prőpilén-karbőnát; 3) őlaj-kőmpőnensként a zsírsavak és primer alkőhőlőkészterei, a közepesen hősszú szénláncú zsírsav-trigliceridek és azsírsav-mőnőgliceridek közül választőtt vagy több anyag, és 4) egy 8és 17 közötti HLB-értékű felületaktív anyag van jelen. Aciklőspőrinkészítmények imműnszűppressziós és gyűlladásgátló hatásúgyógyszerként használhatók. ŕThe subject of the invention is a preparation containing a stone emporium containing cyclamen sporin. The preparation is characterized by the fact that it contains a thermal stone composition, in which 1) cyclamen powder is the active ingredient; 2) propylene carbonate; 3) one or more substances selected from among fatty acids and their primary alkaloids, medium-heat carbon chain fatty acid triglycerides and aziri fatty acid mineral glycerides, and 4) a surfactant with an HLB value of between 8 and 17 is present as a kerosene mineral component. Acyclic powder preparations can be used as immunosuppressive and anti-inflammatory medicines. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970008750A KR19980073479A (en) | 1997-03-14 | 1997-03-14 | Cyclosporine-containing soft capsules |
PCT/EP1998/001432 WO1998041225A1 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0001515A2 true HUP0001515A2 (en) | 2000-09-28 |
HUP0001515A3 HUP0001515A3 (en) | 2000-10-30 |
Family
ID=19499792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0001515A HUP0001515A3 (en) | 1997-03-14 | 1998-03-12 | Pharmaceutical compositions containing cyclosporin |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0969857A1 (en) |
JP (1) | JP3748573B2 (en) |
KR (2) | KR19980073479A (en) |
CN (1) | CN1161150C (en) |
AR (1) | AR012054A1 (en) |
AU (1) | AU741923B2 (en) |
BR (1) | BR9808324A (en) |
CA (1) | CA2283901A1 (en) |
CO (1) | CO4940404A1 (en) |
CZ (1) | CZ324399A3 (en) |
DE (1) | DE19882184T1 (en) |
GB (1) | GB2337703A (en) |
HU (1) | HUP0001515A3 (en) |
ID (1) | ID23531A (en) |
IL (1) | IL131703A0 (en) |
MY (1) | MY118614A (en) |
NO (1) | NO994436L (en) |
PE (1) | PE59499A1 (en) |
PL (1) | PL335729A1 (en) |
RU (1) | RU2185188C2 (en) |
SK (1) | SK123299A3 (en) |
TR (1) | TR199902229T2 (en) |
WO (1) | WO1998041225A1 (en) |
ZA (1) | ZA982117B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2380674B (en) * | 1998-03-06 | 2003-05-28 | Novartis Ag | Emulsion preconcentrates containing cyclosporin or a macrolide |
US7203158B2 (en) * | 2000-12-06 | 2007-04-10 | Matsushita Electric Industrial Co., Ltd. | OFDM signal transmission system, portable terminal, and e-commerce system |
GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5603951A (en) * | 1994-11-09 | 1997-02-18 | Hanmi Pharm. Ind. Co., Ltd. | Cyclosporin-containing soft capsule compositions |
KR0167613B1 (en) * | 1994-12-28 | 1999-01-15 | 한스 루돌프 하우스, 니콜 케르커 | Cyclosporin-containing soft capsule compositions |
WO1997004810A1 (en) * | 1995-07-28 | 1997-02-13 | The Regents Of The University Of California | Dax-1 protein, methods for production and use thereof |
NZ280689A (en) * | 1995-12-15 | 1997-08-22 | Bernard Charles Sherma Sherman | Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol |
KR0183449B1 (en) * | 1996-06-19 | 1999-05-01 | 한스 루돌프 하우스, 니콜 케르커 | Cyclosporin-containing soft capsule preparations |
KR20040000379A (en) * | 1996-06-19 | 2004-01-03 | 노파르티스 아게 | Cyclosporin-containing soft capsule preparations |
-
1997
- 1997-03-14 KR KR1019970008750A patent/KR19980073479A/en active Application Filing
-
1998
- 1998-03-12 ID IDW990997A patent/ID23531A/en unknown
- 1998-03-12 KR KR1019997008022A patent/KR20000075940A/en not_active Application Discontinuation
- 1998-03-12 WO PCT/EP1998/001432 patent/WO1998041225A1/en not_active Application Discontinuation
- 1998-03-12 MY MYPI98001086A patent/MY118614A/en unknown
- 1998-03-12 IL IL13170398A patent/IL131703A0/en unknown
- 1998-03-12 PL PL98335729A patent/PL335729A1/en unknown
- 1998-03-12 CZ CZ993243A patent/CZ324399A3/en unknown
- 1998-03-12 PE PE1998000174A patent/PE59499A1/en not_active Application Discontinuation
- 1998-03-12 CN CNB988033569A patent/CN1161150C/en not_active Expired - Fee Related
- 1998-03-12 CA CA002283901A patent/CA2283901A1/en not_active Abandoned
- 1998-03-12 TR TR1999/02229T patent/TR199902229T2/en unknown
- 1998-03-12 RU RU99121398/14A patent/RU2185188C2/en not_active IP Right Cessation
- 1998-03-12 ZA ZA982117A patent/ZA982117B/en unknown
- 1998-03-12 DE DE19882184T patent/DE19882184T1/en not_active Withdrawn
- 1998-03-12 SK SK1232-99A patent/SK123299A3/en unknown
- 1998-03-12 EP EP98912470A patent/EP0969857A1/en not_active Withdrawn
- 1998-03-12 BR BR9808324-4A patent/BR9808324A/en not_active Application Discontinuation
- 1998-03-12 JP JP54011298A patent/JP3748573B2/en not_active Expired - Fee Related
- 1998-03-12 AU AU67293/98A patent/AU741923B2/en not_active Ceased
- 1998-03-12 GB GB9921495A patent/GB2337703A/en not_active Withdrawn
- 1998-03-12 HU HU0001515A patent/HUP0001515A3/en unknown
- 1998-03-13 CO CO98014254A patent/CO4940404A1/en unknown
- 1998-03-13 AR ARP980101125A patent/AR012054A1/en not_active Application Discontinuation
-
1999
- 1999-09-13 NO NO994436A patent/NO994436L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB9921495D0 (en) | 1999-11-17 |
KR20000075940A (en) | 2000-12-26 |
RU2185188C2 (en) | 2002-07-20 |
AR012054A1 (en) | 2000-09-27 |
JP3748573B2 (en) | 2006-02-22 |
CA2283901A1 (en) | 1998-09-24 |
NO994436D0 (en) | 1999-09-13 |
TR199902229T2 (en) | 1999-12-21 |
WO1998041225A1 (en) | 1998-09-24 |
KR19980073479A (en) | 1998-11-05 |
CN1161150C (en) | 2004-08-11 |
DE19882184T1 (en) | 2000-02-10 |
ID23531A (en) | 2000-04-27 |
PL335729A1 (en) | 2000-05-08 |
SK123299A3 (en) | 2000-02-14 |
ZA982117B (en) | 1998-09-14 |
PE59499A1 (en) | 1999-07-05 |
HUP0001515A3 (en) | 2000-10-30 |
CN1250378A (en) | 2000-04-12 |
BR9808324A (en) | 2000-05-16 |
EP0969857A1 (en) | 2000-01-12 |
AU741923B2 (en) | 2001-12-13 |
MY118614A (en) | 2004-12-31 |
AU6729398A (en) | 1998-10-12 |
GB2337703A (en) | 1999-12-01 |
NO994436L (en) | 1999-09-13 |
CZ324399A3 (en) | 1999-12-15 |
JP2000514831A (en) | 2000-11-07 |
IL131703A0 (en) | 2001-03-19 |
CO4940404A1 (en) | 2000-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY125651A (en) | Eplerenone compositions | |
DE69804624D1 (en) | SELF-TEMPERATURE FORMULATION CONTAINING LIPOPHILE COMPOUNDS | |
CA2294031A1 (en) | Self-emulsifying formulation for lipophilic compounds | |
HUP0400566A2 (en) | Pharmaceutical preparation comprising an active dispersed on a matrix | |
HUP0201444A2 (en) | Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants | |
ATE536173T1 (en) | MODIFIED RELEASE FORMULATIONS OF AT LEAST ONE FORM OF TRAMADOL | |
MY127430A (en) | Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols | |
ATE333267T1 (en) | MICROEMULSION PRECONCENTRATE, MICROEMULSION AND USE OF A COMPOSITION | |
JO2386B1 (en) | Dispersion formulations containing lipase inhibitors | |
KR960021018A (en) | Pharmaceutical composition | |
HUP9801052A2 (en) | Oral cyclosporin formulations | |
HUP0001515A2 (en) | Pharmaceutical compositions containing cyclosporin | |
HUP0100303A2 (en) | Porous hydroxyapatite particles as carriers for drug substances | |
EE05231B1 (en) | Tramadol Hydrochloride Containing Controlled Release Pharmaceutical Composition and Method for its Preparation | |
HUP0003330A2 (en) | Pharmaceutical compositions containing tizoxanide and nitazoxanide | |
JPS5668619A (en) | Nifedipine-containing solid composition | |
PT1128820E (en) | FRAMACEUTIC MIX UNDERSTANDING A COMBINATION OF PROFEN AND OTHER ACTIVE COMPOUNDS | |
HUP0104606A2 (en) | A pharmaceutical mixture comprising a profen | |
AU5058400A (en) | Pharmaceutical composition containing an extrusion additive | |
CA2572498A1 (en) | Biphasic capsule formulation | |
DE69838981D1 (en) | Component and compositions for the administration of active ingredients | |
EP0858805A3 (en) | Transdermal preparations of oxicams | |
TH57976B (en) | Eplyrenone components | |
TH37488A (en) | Pharmaceutical mixtures | |
TH26734B (en) | The cyclodextrin solid mixture prepared by extrusion on melting. |